col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


35 Ergebisse       Seite 1

 [1] 
Wiley: Annals of Neurology
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2024―Nov―22 Neurologic Manifestations of Long COVID Disproportionately Affect Young and Middle-Age Adults Natasha A. Choudhury, Shreya Mukherjee, Tracey Singer, Aditi Venkatesh, Gina S. Perez Giraldo, Millenia Jimenez, et al. (+7)
2 [GO] 2024―Jun―27 Inflammation-Triggered Enlargement of Choroid Plexus in Subacute COVID-19 Patients with Neurological Symptoms Alexander Rau, Gabriel Gonzalez-Escamilla, Nils Schroeter, Ahmed Othmann, Andrea Dressing, Cornelius Weiller, et al. (+4)
3 [GO] 2023―Mrz―26 Neurologic manifestations of long COVID differ based on acute COVID -19 severity Gina S. Perez Giraldo, Sareen T. Ali, Anthony K. Kang, Tulsi R. Patel, Shreya Budhiraja, Jordan I. Gaelen, et al. (+28)
4 [GO] 2022―Okt―17 Ocrelizumab concentration is a good predictor of SARS-CoV -2 vaccination responsein patients with multiple sclerosis Z.L.E. van Kempen, L. Hogenboom, A.A. Toorop, M. Steenhuis, E.W. Stalman, L.Y.L Kummer, et al. (+12)
5 [GO] 2022―Sep―01 Transverse myelitis following SARS-CoV -2 vaccination: a pharmacoepidemiological study in the World Health Organization's database Sophie Nguyen, Etienne Bastien, Basile Chretien, Marion Sassier, Gilles Defer, Ahmad Nehme, et al. (+4)
6 [GO] 2022―Mai―14 Continued false-positive detection of SARS-CoV-2 by electron microscopy C. Dittmayer, M. Laue
7 [GO] 2022―Mrz―15 Cellular and humoral immunity to SARS-CoV -2 infection in multiple sclerosis patients on ocrelizumab and other disease-modifying therapies: a multi-ethnic observational study Ilya Kister, Yury Patskovsky, Ryan Curtin, Jinglan Pei, Katherine Perdomo, Zoe Rimler, et al. (+19)
8 [GO] 2022―Mrz―14 SARS-CoV -2 and mitochondrial proteins in neural-derived exosomes of COVID -19 Michael J. Peluso, Steven G. Deeks, Maja Mustapic, Dimitrios Kapogiannis, Timothy J. Henrich, Scott Lu, et al. (+7)
9 [GO] 2022―Mrz―04 SARS-CoV -2 third vaccine immune response in MS patients treated with ocrelizumab Livnat Brill, Catarina Raposo, Ariel Rechtman, Omri Zveik, Netta Levin, Esther Oiknine-Djian, et al. (+2)
10 [GO] 2022―Feb―12 Implementation of a Teleneurology Clinic in Zambia During the COVID -19 Pandemic Melody Asukile, Lorraine Chishimba, Mashina Chomba, Moses Mataa, Frighton Mutete, Naluca Mwendaweli, et al. (+6)
11 [GO] 2022―Feb―11 COVID-19-associated Critical Illness Myopathy with Direct Viral Effects Dubravka Dodig, Mark A. Tarnopolsky, Marta Margeta, Katerina Gordon, Marvin J. Fritzler, Jian-Qiang Lu
12 [GO] 2022―Feb―07 Reply to ‘Caution regarding conclusions about COVID-19 vaccine and encephalitis’ Frédéric Zuhorn, Tilmann Graf, Randolf Klingebiel, Wolf-Rüdiger Schäbitz, Andreas Rogalewski
13 [GO] 2022―Jan―23 B cell depletion and SARS-CoV -2 vaccine responses in neuroimmunologic patients Barbara Kornek, Fritz Leutmezer, Paulus S Rommer, Maximilian Koblischke, Lisa Schneider, Helmuth Haslacher, et al. (+16)
14 [GO] 2021―Okt―27 Reply to ‘Adenovirus COVID-19 vaccines and Guillain-Barré syndrome with facial paralysis by Dr Pegat et al. BV Maramattom, P Krishnan, R Paul, S Padmanabhan, S Cherukudal Vishnu Nampoothiri, AA Syed, HS. Mangat
15 [GO] 2021―Sep―16 Guillain-Barré Syndrome in an Australian state using both mRNA and adenovirus-vector SARS-CoV -2 vaccines Joshua Osowicki, Hannah Morgan, Adele Harris, Nigel W Crawford, Jim P Buttery, Lynette Kiers
16 [GO] 2021―Jul―29 Postvaccinal encephalitis after ChAdOx1 nCov -19 Frédéric Zuhorn, Tilmann Graf, Randolf Klingebiel, Wolf-Rüdiger Schäbitz, Andreas Rogalewski
17 [GO] 2021―Jun―11 Guillain-Barré syndrome variant occurring after SARS-CoV -2 vaccination Christopher Martin Allen, Shelby Ramsamy, Alexander William Tarr, Patrick Jason Tighe, William Lucien Irving, Radu Tanasescu, Jonathan Rhys Evans
18 [GO] 2021―Jun―11 Guillain-Barré syndrome following ChAdOx1-S / nCoV -19 vaccine Boby Varkey Marammatom, Parameswaran Krishnan, Reji Paul, Sandeep Padmanabhan, C V Soumya, Akheel A. Syed, Halinder S. Mangat
19 [GO] 2021―Apr―09 Approaches to understanding COVID-19 and its neurological associations Ettore Beghi, Benedict D. Michael, Tom Solomon, Erica Westenberg, Andrea S. Winkler, Ettore Beghi, et al. (+53)
20 [GO] 2021―Mrz―11 EEG Abnormalities are Common in COVID-19 and are Associated with Outcomes Lu Lin, Abrar Al-Faraj, Neishay Ayub, Pablo Bravo, Sudeshna Das, Lorenzo Ferlini, et al. (+19)
21 [GO] 2021―Feb―01 To Zoom or Not To Zoom: The Should I Travel Index revisited during the COVID pandemic Seward B. Rutkove, Jeremy M. Shefner, Robert Bowser, Martin R. Turner, Michael Benatar
22 [GO] 2021―Jan―22 Disease modifying therapies and Covid-19 severity in Multiple Sclerosis Maria Pia Sormani, Nicola De Rossi, Irene Schiavetti, Luca Carmisciano, Cinzia Cordioli, Lucia Moiola, et al. (+10)
23 [GO] 2021―Jan―15 Beware of Optimism Bias in the Context of the COVID -19 Pandemic Alvaro Pascual-Leone, Gabriele Cattaneo, Dídac Macià, Javier Solana, José M. Tormos, David Bartrés-Faz
24 [GO] 2020―Dez―18 Pediatric Ischemic Stroke: An Infrequent Complication of SARS-CoV -2 Lauren A. Beslow, Alexandra B. Linds, Christine K. Fox, Manoëlle Kossorotoff, Yenny C. Zuñiga Zambrano, Marta Hernández-Chávez, et al. (+74)
25 [GO] 2020―Dez―10 Incidence, clinical characteristics, risk factors and outcomes of Guillain-Barré syndrome in patients with Covid-19 Marcos Fragiel, Òscar Miró, Pere Llorens, Sònia Jiménez, Pascual Piñera, Guillermo Burillo, et al. (+131)
26 [GO] 2020―Nov―21 The Impact of SARS-CoV -2 on Stroke Epidemiology and Care: A Meta-analysis Aristeidis H. Katsanos, Lina Palaiodimou, Ramin Zand, Shadi Yaghi, Hooman Kamel, Babak B. Navi, et al. (+13)
27 [GO] 2020―Sep―20 MS Disease-Modifying Therapies in the COVID-19 Era John R. Ciotti, Elena Grebenciucova, Brandon P. Moss, Scott D. Newsome
28 [GO] 2020―Aug―01 Reply to the Letter “ Covid-19-associated encephalopathy and cytokine-mediated Neuroinflammation” Andrea Pilotto, Alessandro Padovani
29 [GO] 2020―Jul―27 Covid-19-associated encephalopathy and cytokine-mediated neuroinflammation Lorenzo Muccioli, Umberto Pensato, Ilaria Cani, Maria Guarino, Pietro Cortelli, Francesca Bisulli
30 [GO] 2020―Jul―20 Neurologists' Duties in Planning for Triage of Critical Care Resources in the COVID -19 Pandemic Adeline L. Goss, Winston Chiong, J. Claude Hemphill
31 [GO] 2020―Jul―14 Ethical Justifications for Pandemic Rationing Strategies James L. Bernat
32 [GO] 2020―Mai―23 Crisis Standard of Care: Management of Infantile Spasms during COVID-19 Zachary M. Grinspan, John R. Mytinger, Fiona M. Baumer, Michael A. Ciliberto, Bruce H. Cohen, Dennis J. Dlugos, et al. (+20)
33 [GO] 2020―Mai―17 Pivoting Research to COVID-19 Eric C. Landsness, Shannon C. Agner, Chetan Bettegowda, Justin C. McArthur
34 [GO] 2020―Mai―17 Steroid-responsive encephalitis in Covid-19 disease Andrea Pilotto, Silvia Odolini, S Stefano Masciocchi, Agnese Comelli, Irene Volonghi, Stefano Gazzina, et al. (+12)
35 [GO] 2020―Mai―08 SARS-CoV -2 and Multiple Sclerosis: Not all immune depleting DMTs are equal or bad Sandra Amor, David Baker, Samia J. Khoury, Klaus Schmierer, Gavin Giovanonni
 [1] 

35 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec